# Safety Study of Isentress® + Truvada® in Post-exposure Treatment of HIV Infection

> **NCT01114425** · PHASE3 · COMPLETED · sponsor: **Groupe d'Etude sur le Risque d'Exposition des Soignants aux Agents Infectieux** · enrollment: 149 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** raltegravir (Isentress)
- **DRUG:** Truvada®

## Key facts

- **NCT ID:** NCT01114425
- **Lead sponsor:** Groupe d'Etude sur le Risque d'Exposition des Soignants aux Agents Infectieux
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11-01
- **Primary completion:** 2012-08-01
- **Final completion:** 2012-12-01
- **Target enrollment:** 149 (ACTUAL)
- **Last updated:** 2017-02-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01114425

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01114425, "Safety Study of Isentress® + Truvada® in Post-exposure Treatment of HIV Infection". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01114425. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*